6316-67-2

Basic information

• Product Name: 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI)
• Synonyms: 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI);Nsc22594;4-methylpyridine-3-carbohydrazide
• CAS NO: 6316-67-2
• Molecular Formula: C₇H₉N₃O
• Molecular Weight: 151.165860
• Product Categories: AMIDE
• Mol File: 6316-67-2.mol
• Article Data: 3

Chemical Properties

• Melting Point: 176-177.3℃
• Appearance: /
• Density: 1.195 g/cm³
• Refractive Index: 1.573
• CAS DataBase Reference: 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI)(6316-67-2)
• EPA Substance Registry System: 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI)(6316-67-2)

Safety Data

• Hazardous Substances Data: 6316-67-2(Hazardous Substances Data)

Usage

General Description

3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI), also known as 3-Methylisonicotinic hydrazide, is a chemical compound with the molecular formula C7H9N3O. It is a derivative of 3-pyridinecarboxylic acid and is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 3-Pyridinecarboxylicacid,4-methyl-,hydrazide(9CI) has been studied for its potential antifungal, antitubercular, and cytotoxic properties. It is also used in the production of metal chelates and as a starting material in the preparation of various organic compounds. Additionally, 3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) has been researched for its potential application in the development of anticancer drugs and as a precursor in the synthesis of heterocyclic compounds.

InChI:InChI=1/C7H9N3O/c1-5-2-3-9-4-6(5)7(11)10-8/h2-4H,8H2,1H3,(H,10,11)

Upstream product

• 55314-29-9 4-methylnicotinic acid ethyl ester 
• 33402-75-4 4-methylnicotinic acid methyl ester 
• 3222-50-2 4-methylnicotinic acid 

Downstream Products

• 856858-03-2 (4-methyl-[3]pyridyl)-carbamic acid benzyl ester 
• 3430-27-1 3-amino-4-methylpyridine 
• 883557-66-2 {5-[4-((E)-2-Pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-(4-trifluoromethyl-phenyl)-amine 
• 883557-64-0 [4-(Chloro-difluoro-methoxy)-phenyl]-{5-[4-((E)-2-pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-amine 
• 883557-65-1 {5-[4-((E)-2-Pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-(4-trifluoromethoxy-phenyl)-amine 
• 883557-69-5 {5-[4-((E)-2-Pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-(3-trifluoromethoxy-phenyl)-amine 
• 883557-32-2 {5-[4-((E)-2-Pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-(3-trifluoromethyl-phenyl)-amine 
• 883557-56-0 (4-tert-butyl-phenyl)-{5-[4-(2-pyridin-4-yl-vinyl)-pyridin-3-yl]-[1,3,4]oxadiazol-2-yl}-amine 
• 883557-11-7 [5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-(3-trifluoromethoxy-phenyl)-amine 
• 883557-05-9 [5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-(4-trifluoromethoxy-phenyl)-amine 
• 883557-07-1 [5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-(4-trifluoromethyl-phenyl)-amine 
• 883556-83-0 [5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-(3-trifluoromethyl-phenyl)-amine 
• 883557-04-8 [4-(chloro-difluoro-methoxy)-phenyl]-[5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-amine 
• 883556-93-2 (4-tert-butyl-phenyl)-[5-(4-methyl-pyridin-3-yl)-[1,3,4]oxadiazol-2-yl]-amine 

Relevant articles and documents

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures where the definitions of the variables are provided herein.

Inhibitors of VEGF receptors-1 and -2 based on the 2-((pyridin-4-yl)ethyl) pyridine template

We have developed a series of novel potent ((pyridin-4-yl)ethyl)pyridine derivatives active against kinases VEGFR-1 and -2. Both specific and dual ATP-competitive inhibitors of VEGFR-2 were identified. Kinase selectivity could be controlled by varying the